tirzepatide launch Eli Lilly plans to weight-loss drug in emerging markets this year Cipla's New Move in Diabetes

Research presented at ACC.25 and then simultaneously published in The New England Journal of Medicine highlighted the potential cardiovascular benefits of oral semaglutide for patients with type 2 diabetes.[2] Novo Nordisk anticipates FDA approval for oral semaglutide Novo Nordisk funded this analysis

Here's What the Nutrition Label Actually Says How to Eat Avocado for Breakfast for Weight Loss: Portions, Pairings, and 8 Recipes That Actually Work Lemon Balm vs Ozempic for Weight Loss: What the Evidence Says See your options in about 2 minutes Take the free quiz and see what fits you

But if strategies like adjusting your dose (under the care and guidance of your healthcare provider!) and making a few tweaks to your lifestyle dont work, your provider may suggest medication

PlexusDx supports this decision through personalized consultation and the Precision Peptide Genetic Test, which maps 14 biological pathways and provides insights into 150+ genetic factors affecting your peptide response